1. Gain a Deep Insight into the Global Healthcare Cold Chain Logistic Services Market
Driven by a strong demand of biopharmaceuticals, vaccines and clinical trial materials; the global market
for healthcare cold chain logistic services is expected to grow exponentially in the coming years.
IMARC Group, one of the world’s leading research and advisory firms, has recently launched one of the
most comprehensive studies on the global healthcare logistic services market. The study entitled
“Global Healthcare Cold Chain Logistics Market Report & Forecast (2011-2016)” provides an
analytical and statistical insight into the logistic opportunities in the global healthcare market. The study
that has been undertaken using both desk based as well as qualitative primary market research has
analyzed three aspects of the global healthcare cold chain logistics market.
The first aspect involves the quantification of the global market for temperature sensitive healthcare
products into three major classes and evaluation of the current and future opportunities in each of these
classes. The second aspect involves an in-depth understanding on the global healthcare cold chain
distribution process and logistic requirements for various temperature sensitive healthcare products. The
third aspect involves the quantification of the global healthcare cold chain logistic services market and a
comprehensive evaluation of its various segments.
What we have achieved in this report:
Comprehensive Market Analysis of Temperature Sensitive Healthcare Products
Classes Covered: Biopharmaceuticals, Vaccines & Clinical Trial Material
Focus of the Analysis in Each Class:
• Drivers and challenges
• Historical sales trends
• Logistic requirements
• Impact of temperature excursions
• Opportunities in cold chain services
• Market outlook (2011-2016)
Understanding the Operations of a Healthcare Cold Chain Distribution Process
Focus of the Analysis:
• Understanding the various methods of cold chain distribution and their advantages/disadvantages.
• Understanding the cold chain requirements for various temperature sensitive healthcare products and
the impact of temperature excursions.
• Understanding the various costs involved in cold chain transportation and comparing it with non-cold
chain transportation.
• Understanding the key steps required in the setting and organization of an efficient cold chain
distribution process.
imarc© 1

2. Comprehensive Market Analysis of the Healthcare Cold Chain Logistic Services Market
Focus of the analysis:
• Quantifying the global healthcare cold chain logistic services market
• Quantifying the market size by product
• Quantifying the market size by service
• Quantifying the market size by region
Information Sources:
Information has been sourced from both primary and secondary sources:
Primary sources include industry surveys and face to face/telephone interviews with industry experts.
Secondary sources include proprietary databases and search engines. These sources include company
websites and reports, books, trade journals, magazines, white papers, industry portals, government
sources and access to more than 4000 paid databases.
Table of Contents:
1 Research Methodology & Market Definitions
2 Executive Summary
3 The Global Healthcare Cold Chain Logistics Market
3.1 Current Trends
3.1.1 Healthcare Cold Chain Products are Exhibiting Exponential Growth
3.1.2 Temperature Sensitive Healthcare Products Have Well Defined Logistic Needs
3.1.3 Outsourcing Trends in Research & Manufacturing Have Increased Logistic Demands
3.1.4 Increasing Regulatory Focus on the Integrity of Transported Healthcare Products
3.1.5 Cost is Not Always the Most Important Driver in Supplier Decisions
4 The Global Healthcare Cold Chain Products Market
4.1 Current Market Trends & Forecast
4.2 Market Segments
4.2.1 Biopharmaceuticals
4.2.1.1 Current Market Trends & Forecast
4.2.1.2 Cold Chain Requirements for Biopharmaceuticals
4.2.1.3 Cold Chain Opportunities for Biopharmaceuticals
4.2.2 Vaccines
4.2.2.1 Current Market Trends & Forecast
4.2.2.2 Cold Chain Requirements for Vaccines
4.2.2.3 Cold Chain Opportunities for Vaccines
4.2.3 Clinical Trial Materials
4.2.3.1 Current Market Trends & Forecast
4.2.3.2 Cold Chain Requirements for Clinical Trial Materials
4.2.3.3 Cold Chain Opportunities for Clinical Trial Materials
5 Healthcare Cold Chain Logistics: How Does It Operate?
5.1 Cold Chain Packaging & Transportation Methods
5.1.1 Dry Ice
5.1.2 Liquid Nitrogen
5.1.3 Gel Packs
5.2 Modeling the Cost of Cold Chain Packaging & Transportation
5.3 The Setting & Organization of Cold Chains
5.3.1 Initial Considerations
5.3.2 Choosing the Correct Model
5.3.3 Regulatory/Custom Clearance
imarc© 2

3. 5.3.4 Final Stages
5.3.5 Quality Assurance
6 The Healthcare Cold Chain Logistic Services Market
6.1 Current Trends & Forecast
6.2 Market Segmentation
6.2.1 Market by Product
6.2.1.1 Biopharmaceuticals & Vaccines
6.2.1.2 Clinical Trial Materials
6.2.2 Market by Service
6.2.2.1 Packaging & Instrumentation
6.2.2.2 Transportation
6.2.3 Market by Region
6.2.3.1 North America
6.2.3.2 Europe
6.2.3.3 Asia Pacific
6.2.3.4 Rest of the World
7 Challenges in the Healthcare Cold Chain Logistics Market
7.1 Cold Chain Infrastructure Remains Underdeveloped in Many Regions
7.2 Lack of Funding to Implement an Efficient Cold Chain Infrastructure
7.3 New Technologies Nullifying the Need of Cold Chains
8 Key Company Profiles
8.1 World Courier
8.2 DHL
8.3 Fedex
8.4 United Parcel Service
8.5 Kuehne and Nagel
8.6 Cavalier Logistics
8.7 DB Schenker
8.8 Life ConEx
8.9 American Airlines Cargo
8.10 Continental Air Cargo
8.11 Marken
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-425-6531
IMARC Group North America
Email: america@imarcgroup.com
Phone: +1-631-791-1145
To know more please visit: http://www.imarcgroup.com/global-healthcare-cold-chain-
logistics-market-report-forecast-2011-2016/
imarc© 3

4. Key words
Biosimilar market, biosimilar industry, follow-on biologics market, biogenerics market, us biosimilar
market, biosimilar monoclonal antibodies
imarc© 4